Home > Insider Trading > Filing (0001225208-25-001683)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885725	Boston Scientific Corp	BSX	Surgical & Medical Instruments & Apparatus (3841)	042695240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1484186	Michael Joseph Fitzgerald	300 Boston Scientific Way Marlborough MA 01752-1234	Evp & Group Pres, Cardiology	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-12-03	50	$90.29	148,168	No	4	P	Direct
Common Stock	Disposition	2024-12-10	20	$89.97	148,148	No	4	S	Direct
Common Stock	Acquisiton	2025-02-11	31,680	$0.00	187,310	No	4	A	Direct
Common Stock	Disposition	2025-02-11	14,447	$105.98	172,863	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	S	Direct
No	4	A	Direct
No	4	F	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,894	Indirect	By Child

Footnotes

This transaction was inadvertently effected by a broker through a broker managed account, without any instruction from or knowledge of the reporting person.
On February 16, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Total Shareholder Return Performance Share Program, with the actual number to be earned by the reporting person to be based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Health Care Index over the three-year performance cycle comprising the three-year period ended December 31, 2024 and subject to the completion of the concurrent three-year individual service period. On February 11, 2025, the number of performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied.
The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose.